Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme

Research output: Contribution to journal › Review › Research › peer-review

Standard

Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme. / Zhao, Mirabella; Wewer, Mads Damsgaard; Bjerrum, Jacob Tveiten; Steenholdt, Casper; Schiødt, Frank; Haderslev, Kent; Kiszka-Kanowitz, Marianne; Munkholm, Pia; Seidelin, Jakob; Burisch, Johan.

In: Ugeskrift for Laeger, Vol. 184, No. 11, V09210706, 2022.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Zhao, M, Wewer, MD, Bjerrum, JT, Steenholdt, C, Schiødt, F, Haderslev, K, Kiszka-Kanowitz, M, Munkholm, P, Seidelin, J & Burisch, J 2022, 'Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme', Ugeskrift for Laeger, vol. 184, no. 11, V09210706. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v09210706_web.pdf>

APA

Zhao, M., Wewer, M. D., Bjerrum, J. T., Steenholdt, C., Schiødt, F., Haderslev, K., Kiszka-Kanowitz, M., Munkholm, P., Seidelin, J., & Burisch, J. (2022). Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme. Ugeskrift for Laeger, 184(11), [V09210706]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v09210706_web.pdf

Vancouver

Zhao M, Wewer MD, Bjerrum JT, Steenholdt C, Schiødt F, Haderslev K et al. Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme. Ugeskrift for Laeger. 2022;184(11). V09210706.

Author

Zhao, Mirabella ; Wewer, Mads Damsgaard ; Bjerrum, Jacob Tveiten ; Steenholdt, Casper ; Schiødt, Frank ; Haderslev, Kent ; Kiszka-Kanowitz, Marianne ; Munkholm, Pia ; Seidelin, Jakob ; Burisch, Johan. / Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme. In: Ugeskrift for Laeger. 2022 ; Vol. 184, No. 11.

Bibtex

@article{6a931ef5b5844e50bf5d176d4d86e433,
title = "Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme",
abstract = "Despite the increasing availability of biological treatment in recent years, thiopurines remain an important treatment option in patients with inflammatory bowel diseases (IBD) both as monotherapy and in combination therapy with biologicals. Pre-treatment screening of thiopurine-methyltransferase activity and monitoring of thiopurine metabolites during treatment are essential to optimize the effectiveness and safety of thiopurines. This review provides an evidence-based practical guide to prescribing and monitoring thiopurines in patients with IBD.",
author = "Mirabella Zhao and Wewer, {Mads Damsgaard} and Bjerrum, {Jacob Tveiten} and Casper Steenholdt and Frank Schi{\o}dt and Kent Haderslev and Marianne Kiszka-Kanowitz and Pia Munkholm and Jakob Seidelin and Johan Burisch",
year = "2022",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "11",

}

RIS

TY - JOUR

T1 - Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme

AU - Zhao, Mirabella

AU - Wewer, Mads Damsgaard

AU - Bjerrum, Jacob Tveiten

AU - Steenholdt, Casper

AU - Schiødt, Frank

AU - Haderslev, Kent

AU - Kiszka-Kanowitz, Marianne

AU - Munkholm, Pia

AU - Seidelin, Jakob

AU - Burisch, Johan

PY - 2022

Y1 - 2022

N2 - Despite the increasing availability of biological treatment in recent years, thiopurines remain an important treatment option in patients with inflammatory bowel diseases (IBD) both as monotherapy and in combination therapy with biologicals. Pre-treatment screening of thiopurine-methyltransferase activity and monitoring of thiopurine metabolites during treatment are essential to optimize the effectiveness and safety of thiopurines. This review provides an evidence-based practical guide to prescribing and monitoring thiopurines in patients with IBD.

AB - Despite the increasing availability of biological treatment in recent years, thiopurines remain an important treatment option in patients with inflammatory bowel diseases (IBD) both as monotherapy and in combination therapy with biologicals. Pre-treatment screening of thiopurine-methyltransferase activity and monitoring of thiopurine metabolites during treatment are essential to optimize the effectiveness and safety of thiopurines. This review provides an evidence-based practical guide to prescribing and monitoring thiopurines in patients with IBD.

M3 - Review

C2 - 35315759

AN - SCOPUS:85126837588

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 11

M1 - V09210706

ER -

ID: 344374630